Skip to main content

Table 1 Description of the included studies

From: Systematic review and meta-analysis of propofol versus barbiturates for controlling refractory status epilepticus

Authors Year Cases (N) Age (Years) Gender (Male/female) (N) APACHE II
All Propofol Barbiturates Propofol Barbiturates Propofol Barbiturates Propofol Barbiturates
van Gestel JP [14] 2005 42 22 20
Xiuquan F [12] 2005 18 9 9 45.2 46.3 4 5 6 3 26.5 23.9
Zengming W [11] 2011 14 7 7 41.2 43.3 3 4 5 2 23.5 22.9
Rossetti AO [15] 2011 23 14 9 57 (26–87) 64 (16–78) 7 7 3 6
Xiang C [13] 2016 18 9 9 45.2 ± 2.35 45.0 ± 2.39 6 3 7 2 24.1 24
Chunfen Z [17] 2017 90 45 45 26.3 ± 2.5 26.6 ± 2.6 23 22 24 21
Linzhi C [16] 2017 56 28 28 40.86 ± 2.89 41.35 ± 3.15 15 13 18 10
  1. N, cases, APACHE II, Acute Physiology and Chronic Health Evaluation II